Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 2/20 | 0.39 |
| ▸ | GRM2 | Q14416 | 11/20 | 0.38 |
| ▸ | CALML3 | P27482 | 3/20 | 0.37 |
| ▸ | MAOA | P21397 | 1/20 | 0.36 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6372043 | 1.00 | MAOB (0.39) | MAOBGRM2CALML3MAOASIGMAR1 | |
| SCHEMBL6209091 | 0.86 | GRM2 (0.39) | MAOBGRM2CALML3MAOA | |
| SCHEMBL6192456 | 0.86 | GRM2 (0.39) | MAOBGRM2CALML3MAOA | |
| SCHEMBL633077 | 0.85 | SIGMAR1 (0.46) | MAOBGRM2MAOASIGMAR1 | |
| SCHEMBL591031 | 0.85 | SIGMAR1 (0.46) | MAOBGRM2MAOASIGMAR1 | |
| SCHEMBL1842478 | 0.85 | SIGMAR1 (0.46) | MAOBGRM2MAOASIGMAR1 | |
| SCHEMBL6192191 | 0.84 | GRM2 (0.39) | MAOBGRM2CALML3MAOA | |
| SCHEMBL6212026 | 0.84 | GRM2 (0.39) | MAOBGRM2CALML3MAOA | |
| SCHEMBL6210949 | 0.82 | CALML3 (0.54) | MAOBGRM2CALML3MAOASIGMAR1 | |
| SCHEMBL6365183 | 0.82 | CALML3 (0.54) | MAOBGRM2CALML3MAOASIGMAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050277630-A1 | Antibacterial agents | CHUPAK LOUIS S | 2005-12-15 | — | — | US | disclosed |
| EP-1594495-A1 | OXAZOLIDINONE DERIVATES N-SUBSTITUTED BY A TRICYCLIC RING, FOR USE AS ANTIBACTERIAL AGENTS | Warner-Lambert Company LLC (US) | 2005-11-16 | — | — | EP | disclosed |
| WO-2004069245-A1 | OXAZOLIDINONE DERIVATES N-SUBSTITUTED BY A TRICYCLIC RING, FOR USE AS ANTIBACTERIAL AGENTS | WARNER-LAMBERT COMPANY LLC (US) | 2004-08-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050277630-A1 | Antibacterial agents | MRPL21, RPN2, FBL | MAOB 221/4885GRM2 4785/4885CALML3 4366/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.